Adults with subjective cognitive decline were more likely to report 4 modifiable risk factors for Alzheimer's disease
Among survey respondents ages 45 years and older, the most common modifiable risk factor for Alzheimer's disease and related dementias was hypertension (49.9%), followed by not meeting guidelines for aerobic physical activity (49.7%), obesity (35.3%), and diabetes (18.6%).
31 May 2022
A study found that patients with Alzheimer's disease and related dementias were more likely to miss payments on credit accounts as early as six years before diagnosis and to develop subprime credit scores 2.5 years before diagnosis.
1 May 2022
Patients who had taken benzodiazepines for at least 3 months had a 50% increased risk of Alzheimer's disease, a recent study of older patients found.
16 Sep 2014
Primary care physicians can expect to diagnose an increasing number of patients with Alzheimer's disease as the U.S. population ages. While clinicians have been more successful in diagnosing the disease early, effective treatments or prevention options are more scarce.
1 Mar 2016
Patients with Alzheimer's disease who develop delirium during hospitalization are more likely to have adverse outcomes, according to a new study.
19 Jun 2012
Because neurocognitive decline can have a variety of etiologies, a new definition by the DSM-5 defined mild cognitive impairment as a syndrome, and then drilled down to its etiology.
1 Jul 2019
Taking 2,000 IU of vitamin E daily slowed functional decline and reduced caregiver time in patients with mild to moderate Alzheimer's disease, a study found.
7 Jan 2014
New technology and biomarkers have contributed to the detection of Alzheimer's disease, but clinicians are skeptical about the value of a diagnosis without the ability to treat the condition.
1 Nov 2019
An accompanying editorial noted that while some tools are available to identify, diagnose, and treat cognitive dysfunction from Alzheimer's dementia, they are blunt and lack clinical utility.
28 Apr 2020
The findings of this retrospective study in the United Kingdom should reassure women taking menopausal hormonal therapy but do not support its use to prevent dementia, a linked opinion piece said.
5 Oct 2021